Why the study?
Does a short-term adherence measure predict composite clinical outcomes as well as the HEDIS definition in post-MI patients on beta-blockers?
Population
8,672 post-myocardial infarction patients aged 18 years and older
Comparison
Short-term adherence measure for beta-blocker use vs HEDIS definition of adherence
Design
Cohort
Authors
Loading...
May enable earlier post-MI beta-blocker adherence assessment; leaves open prospective validation versus HEDIS for outcome prediction.
Does a short-term adherence measure predict composite clinical outcomes as well as the HEDIS definition in post-MI patients on beta-blockers?
A short-term 90-day adherence measure for beta-blocker use post-MI predicts clinical outcomes as well as the standard HEDIS measure, allowing for faster quality assessment.
Sanfélix‐Gimeno et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: